Ixiaro (IC51) / Valneva 
Welcome,         Profile    Billing    Logout  
 20 Diseases   7 Trials   7 Trials   127 News 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ixiaro (IC51) / Valneva
2010-020450-33: Detailed analysis of the immune responses after vaccination against Japanese Encephalitis in the elderly.

Ongoing
4
60
Europe
IXIARO, IXIARO(R), IXIARO(R)
Institute of Specific Prophylaxis and Tropical Medicine, Institute of Specific Prophylaxis and Tropical Medicine
The aim of this project is to investigate humoral and cellular immune responses before and after immunisation with the Japanese encephalitis vaccine IXIARO in subjects above 65 years of age in comparison to subjects aged between 18 and 40 years.
 
 
2013-001954-88: Immune response to intradermally administered Ixiaro in healthy adults

Ongoing
3/4
240
Europe
Ixiaro
Helsinki University Centrel Hospital
18-64 years old volunteers with general good health, 18-64 years old volunteers with general good health
 
 
ACTRN12605000680662: Safety and Tolerability Study of the JE Vaccine IC51

Not yet recruiting
3
600
 
Intercell AG, Intercell AG
Prophylactic Vaccine against Japanese Encephalitis
 
 
ACTRN12605000681651: Long Term Immunogenicity of the JE Vaccine IC51

Not yet recruiting
3
600
 
Intercell AG, Intercell AG
Prophylactic Vaccine against Japanese Encephalitis
 
 
2017-002137-32: Immunological responses after concomitant vaccination with the yellow fever-vaccine and the TBE-vaccine, or JE-vaccine Immunologiskt svar efter samtidig vaccinering med gula febern vaccinet och TBE-vaccinet, respektive JE-vaccinet

Ongoing
2
140
Europe
Suspension for injection, Suspension for injection in pre-filled syringe, Stamaril, FSME Immun, Ixiaro
Hans-Gustaf Ljunggren, Karolinska Institutet
Prevention of TBE or Japanece encephalitis by co-vaccination with the yellow fever vaccine Prevention mot TBE och Japansk encefalit genom samtidig vaccinering med gula febern vaccinet, Prevention of TBE or Japanece encephalitis by co-vaccination with the yellow fever vaccine Förebyggande av TBE och Japansk encefalit genom samtidig vaccinering med gula febern vaccinet, Diseases [C] - Virus Diseases [C02]
 
 
NCT05568953: An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity

Recruiting
2
70
RoW
Stamaril, YF17D vaccine, Imojev, JE-YF17D vaccine, Ixiaro, Inactivated Japanese Encephalitis vaccine
Singapore General Hospital, Duke-NUS Graduate Medical School
Infectious Disease, Yellow Fever, Japanese Encephalitis, Viral Infection
10/25
10/25
NCT06680128: A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults

Recruiting
1/2
402
RoW
GBP560-A, GBP560-B, IXIARO, IMOJEV, Normal Saline (Placebo)
SK Bioscience Co., Ltd.
Japanese Encephalitis Virus Disease
06/26
03/28
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ixiaro (IC51) / Valneva
2010-020450-33: Detailed analysis of the immune responses after vaccination against Japanese Encephalitis in the elderly.

Ongoing
4
60
Europe
IXIARO, IXIARO(R), IXIARO(R)
Institute of Specific Prophylaxis and Tropical Medicine, Institute of Specific Prophylaxis and Tropical Medicine
The aim of this project is to investigate humoral and cellular immune responses before and after immunisation with the Japanese encephalitis vaccine IXIARO in subjects above 65 years of age in comparison to subjects aged between 18 and 40 years.
 
 
2013-001954-88: Immune response to intradermally administered Ixiaro in healthy adults

Ongoing
3/4
240
Europe
Ixiaro
Helsinki University Centrel Hospital
18-64 years old volunteers with general good health, 18-64 years old volunteers with general good health
 
 
ACTRN12605000680662: Safety and Tolerability Study of the JE Vaccine IC51

Not yet recruiting
3
600
 
Intercell AG, Intercell AG
Prophylactic Vaccine against Japanese Encephalitis
 
 
ACTRN12605000681651: Long Term Immunogenicity of the JE Vaccine IC51

Not yet recruiting
3
600
 
Intercell AG, Intercell AG
Prophylactic Vaccine against Japanese Encephalitis
 
 
2017-002137-32: Immunological responses after concomitant vaccination with the yellow fever-vaccine and the TBE-vaccine, or JE-vaccine Immunologiskt svar efter samtidig vaccinering med gula febern vaccinet och TBE-vaccinet, respektive JE-vaccinet

Ongoing
2
140
Europe
Suspension for injection, Suspension for injection in pre-filled syringe, Stamaril, FSME Immun, Ixiaro
Hans-Gustaf Ljunggren, Karolinska Institutet
Prevention of TBE or Japanece encephalitis by co-vaccination with the yellow fever vaccine Prevention mot TBE och Japansk encefalit genom samtidig vaccinering med gula febern vaccinet, Prevention of TBE or Japanece encephalitis by co-vaccination with the yellow fever vaccine Förebyggande av TBE och Japansk encefalit genom samtidig vaccinering med gula febern vaccinet, Diseases [C] - Virus Diseases [C02]
 
 
NCT05568953: An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity

Recruiting
2
70
RoW
Stamaril, YF17D vaccine, Imojev, JE-YF17D vaccine, Ixiaro, Inactivated Japanese Encephalitis vaccine
Singapore General Hospital, Duke-NUS Graduate Medical School
Infectious Disease, Yellow Fever, Japanese Encephalitis, Viral Infection
10/25
10/25
NCT06680128: A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults

Recruiting
1/2
402
RoW
GBP560-A, GBP560-B, IXIARO, IMOJEV, Normal Saline (Placebo)
SK Bioscience Co., Ltd.
Japanese Encephalitis Virus Disease
06/26
03/28

Download Options